PHARMACEUTICAL FORMULATIONS / DRUG FORMULATIONS
We are the leading pharmaceutical formulations manufacturer for
various ailments. We lead in pharmaceutical drug
formulations with range of quality drugs like oral cephalosporin, sterile cephalosporin,
anti-protozoal drugs, anti-malarial drugs, anti-anemia drugs,
anti-bacterial, anti-allergics, vitamins, semi synthetic penicillin
injectable products and many more. We as pharmaceutical formulations exporter / drug formulations
exporter focus on quality of the drugs and timely delivery.
| Sr. No. | Composition | Label Claim | Packing Size |
| Pre-Filled Syringes Composition | |||
| 1 | Hydroxy Propylmethyl Cellulose Opthalmic Solution USP | 2.00% | 2ml |
| 2 | Enoxparin Injection | 100 mg/ml | 80 mg/0.8 ml |
| 3 | Enoxparin Injection | 100 mg/ml | 60 mg/0.6 ml |
| 4 | Enoxparin Injection | 100 mg/ml | 40 mg/0.4 ml |
| 5 | Enoxparin Injection | 100 mg/ml | 20 mg/0.2 ml |
| 6 | Dalteparin Injection | 10000IU/ml | 1.0 ml |
| 7 | Nadroparin Calcium 11,400 IU/0.6 ml Solution for Injection | 19000IU/ml | 11,400 IU/0.6 ml |
| 8 | Low-Molecular Weight Heparin Sodium | 25000IU/ml | 5000 IU/0.2 ml |
| 9 | Low-Molecular Weight Heparin Sodium | 12500IU/ml | 2500 IU/0.2 ml |
| 10 | Low-Molecular Weight Heparin Sodium | 25000IU/ml | 10000 IU/0.4 ml |
| 11 | Low-Molecular Weight Heparin Sodium | 25000IU/ml | 12500 IU/0.5 ml |
| 12 | Low-Molecular Weight Heparin Sodium | 25000IU/ml | 15000 IU/0.6 ml |
| 13 | Low-Molecular Weight Heparin Sodium | 25000IU/ml | 18000 IU/0.72 ml |
| 14 | Low-Molecular Weight Heparin Sodium | 10000IU/ml | 7500 IU/0.75 ml |
| 15 | Low-Molecular Weight Heparin Sodium | 10000IU/ml | 10000 IU/1.0 ml |
| 16 | Vasopressin | 20 IU/ml | 1.0 ml |
| 17 | Vasopressin | 40 IU/ml | 1.0 ml |
| 18 | Recombinant Human Erythropoietin | 2000 IU/ml | 0.5 ml |
| 19 | Recombinant Human Erythropoietin | 4000 IU/ml | 0.4 ml |
| Sr.No. | Composition | Packing |
| 1 | Ciprofloxacin Injection IP (2% W/V) | 100 ml |
| 2 | Ciprofloxacin Intravenous Infusion | 100 ml |
| 3 | Dextrose Injection | 100 ml |
| 4 | Mannitol Injection | 100 ml |
| 5 | Metronidazole Injection (0.5% W/V) | 100 ml |
| 6 | Linezolid Injection (0.2% w/v) | 100 ml |
| 7 | Ofloxacin Influsion (0.2% W/V) | 100 ml |
| 8 | Levofloxacin Intravenous Infusion (0.5% w/v) | 100 ml |
| 9 | Ornidazole Infusion (0.5% W/V) | 100 ml |
| 10 | Moxifloxacin Intravenous Infusion (0.4% W/V) | 100 ml |
| 11 | Fluconazole Infusion (0.2% WW/V) | 100 ml |
| 12 | Gatifloxacin Infusion IP | 100 ml |
| 13 | Levofloxacin Infusion (0.5% W/V) | 100 ml |
| 14 | Paracetamol | 100 ml |
| 15 | Paracetamol + Diclofenac Injection | 100 ml |
| Sr.No. | Composition | Packing | |
| 1 | Each Combikit contains: A) 1 Azithromycin Tablet 1 gm B) 1 Fluconazole Tablet 150 mg C) 2 Secnidazole Tablet 1 gm | 1 X 1 | Blister |
| 2 | A combipack for seven days therapy, Each pack contains: For Day 1 3 Quinine Sulpahte Tablets IP Each coated tablet contains: Quinine Sulphate IP 600 mg Colour: Erythrosine 2. Doxycycline Capsule IP Each hard gelatin capsule contains: Doxycycline Hydrochloride IP e.q. To Doxycycline 100 mg Approved colours used in capsule shells Each Day for Day 2 to 7: 3 Quinine Sulphate Tablets IP Each coated tablet contains: Quinine Sulphate IP 600 mg Colour: Erythrosine 1 Doxycycline Capsule IP Each hard gelatin capsule contains: Doxycycline Capsule IP Each hard gelatin capsule contains: Doxycycline Hydrochloride IP e.q. To Doxycycline 100 mg Approved colours used in capsule shells | 1 X 1 | Blister |
| 3 | Each kit contains: Each coated tablet contains: Artesunate 200 mg Each tablet contains: Pyrimethamine BP 25 mg Sulfamethoxypyrazine 500 mg | 1 X 1 | |
| 4 | Each combkit contains: (A) Clarithromycin Tablet USP Each film coated tablet contains: Clarithromycin USP 250 mg Colour : Quinoline Yellow WS & Titanium Dioxide BP (B) Tinidazole Tablets Each film coated tablet contains: Tinidazole BP 250 mg Colour : Titanium Dioxide BP (C) Lansoprazole Delayed- Release Capsule USP Each hard gelatin capsule contains: Lansoprazole US 30 mg (enteric coated granules) | 1 X 1 | Blister |
| 5 | Each combinational kit contains: 1 Labeled blister of 6 Tablets of Amodiaquine Hydrochloride USP eq. to Amodiaquine 153.1 mg 1 Labeled blister of 6 Tablets of Artesunate 50 mg | 1 X 1 | Blister |
| 6 | Each kit contains: (A) 2 Amoxicillin Tablets BP Each film coated tablet contains: Amoxicillin Trihydrate IP Eq. to Amoxicillin 750mg Colour: Sunset Yellow FCF (B) 2 Tinidazole Tablet IP Each film coated tablet contains: Tinidazole IP 500mg Colour: Quinoline Yellow WS & Titanium Dioxide IP (C) 2 Omeprazole Capsule IP Each hard gelatin capusle contains: Omeprazole IP 20mg (As enteric coated granules) Appoved colours used in empty capsule | 1 X 1 | Blister |
| 7 | Each combikit contains: (A) Quinoline Sulphate Tablets IP Each coated tablet contains: Quinoline Sulphate IP 600 mg Colour: Erythrosine (B) Azithromycin Tablets Each film coated tablet contains: Azithromycin USP eq to Anhydrous Azithromycin 500 mg Colour: Yellow Oxide of Iron | 1 X 1 | Blister |
| 8 | Each Kit contains: (A) Haematinic Tablet Each film coated tablet contains: Ferrous Ascorbate Eq. to Elemental Iron 100mg Folic Acid IP 1.5mg Methylcobalamin 500mcg Zinc Sulphate IP 61.8mg Colours: Ponceau 4R & Titanium Dioxide IP (B) Calcium & Vitamin D3 Tablet Each film coated tablet contains: Calcium Carbonate IP eq. to Elemental Calcium 500mg Vitamin D3 IP 200 IU Colour: Brilliant Blue FCF | 1 X 1 | Blister |
| 9 | A combipack for seven days therapy, Each pack contains: For Day 1 3 Quinine Sulphate Tablets IP Each coated tablet contains: Quinine Sulphate IP 600 mg Colour: Erythrosine 2. Doxycycline Capsule IP Each hard gelatin capsule contains: Doxycycline Hydrochloride IP e.q. to Doxycycline 100 mg Approved colours used in capsule shells. Each Day for Day 2 to 7: 3 Quinine Sulphate Tablets IP Each coated tablet contains: Quinine Sulphate IP 600 mg Colour: Erythrosine 1 Doxycycline Capsule IP Each hard gelatin capsule contains: Doxycycline Capsule IP Each hard gelatin capsule contains: Doxycycline Hydrochloride IP e.q. to Doxycycline 100 mg Approved colours used in capsule shells | 1 X 1 | Blister |
| Sr.No. | Product | Strength | Packing |
| 1 | Amoxycillin 250 gm + Cloxacillin 250 gm | 250gm | Pouch |
| 2 | Amoxycillin 50 gm + Cloxacillin 50 gm | 50gm | Pouch |
| 3 | Cholestyramine | 5gm | Pouch |
| Product | Strength | Form | Packin | Categogry | Indication |
| hMg | 75 IU 150 IU | Lyophilised Injection Lyophilised Injection | 5 X 2 ml vial 5 X 2 ml vial | Gonadotrophin | Infertility |
| FSH | 75 IU 150 IU | Lyophilised Injection Lyophilised Injection | 5 X 2 ml vial 5 X 2 ml vial | Gonadotrophin | Infertility |
| hCG | 2000 IU 5000 IU 10000 IU | Lyophilised Injection Lyophilised Injection Lyophilised Injection | 5 X 2 ml vial 5 X 2 ml vial 5 X 2 ml vial | Gonadotrophin | Infertility |
| Isoxsuprine | 2 ml 10 mg | Liquid Injection Tablet | 5 X 2 ml ampoule 10 X 10's Blister | Beta-Stimulant | Premature Labour & Threatened abortion |
| Tranexamic Acid | 5 ml 500 mg | Liquid Injection Tablet | 3 X 5 ml ampoule 5 X 6's Blister | Anti-fibrinolytic | Menorrhagia, DUB & Postpartum bleeding |
| Glycine Sulphate 50 + Carbonyl Iron 50 | 100 mg | Capsules | 10 X 10's Blister | Hematinic | Iron deficiency anemia |
| Clotrimazole | 10 mg/ml | Lotion | Bottle of 15 ml | ||
| Clotrimazole | 1% w/w | Cream | Tube of 10 gm | ||
| Clotrimazole | 1% w/w | Dusting Powder |
| Product | Strength | Form | Packing | Category | Indication |
| Esomeprazole | 40 mg 20 mg 40 mg | Lyophilised Injection Tablet Tablet | 10 ml vial | Proton Pump Inhibitor | Stress Ulcer, Acid Peptic Disorder |
| Rabeprazole | 20 mg 10 mg 20 mg | Lyophilised Injection Tablet Tablet | 10 X 10's Alu foil 5 X 10's Alu foil | Proton Pump Inhibitor, Antiulcer | Stress Ulcer, Acid Peptic Disorder |
| Pantoprazole | 40 mg | Lyophilised Injection | 15 ml vial | Proton Pump Inhibitor, Antiulcer | Stress Ulcer, Acid Peptic Disorder |
| Omeprazole | 40 mg 20 mg | Lyophilised Injection Capsules | 10 ml vial 10 X 10's Blister | Proton Pump Inhibitor, Antiulcer | Stress Ulcer, Acid Peptic Disorder |
| Itopride HCL | 50 mg | Tablet | 10 X 10's Blister | Prokinetic | GERD |
| 1 | Hyaluronidase for Inj IP 1500 IU | Lyophilized |
| 2 | Hyaluronidase for Inj IP 3 mg | Lyophilized |
| 3 | Menotropin for Inj BP (HMG) 150 IU | Lyophilized |
| 4 | Menotropin for Inj BP (HMG) 75 IU | Lyophilized |
| 5 | Methyl Prednisolone Sodium Succinate 500 mg | Dry Powder |
| 6 | Methyl Prednisolone Sodium Succinate 1 gm | Dry Powder |
| 7 | Somatostatin for Inj 250 mcg | Lyophilized |
| 8 | Streptokinase Injection IP 750000 IU | Lyophilized |
| 9 | Streptokinase Injection IP 1500000 IU | Lyophilized |
| 10 | Urofollitrophin for Inj BP (FSH) 75 IU | Lyophilized |
| 11 | Urofollitrophin for Inj BP (FSH) 150 IU | Lyophilized |
| 12 | Human Chorionic Gonadotrophin for Inj (HCG) 2000 IU | Lyophilized |
| 13 | Human Chorionic Gonadotrophin for Inj (HCG) 5000 IU | Lyophilized |
| 14 | Human Chorionic Gonadotrophin Inj (HCG) 10000 IU lyophilized | Lyophilized |
| 15 | Eptifibatide Inj 20 mg | Liquid |
| 16 | Meropenem Inj USP 500 mg | Dry Powder |
| 17 | Meropenem Inj USP 1000 mg | Dry Powder |
| 18 | Amphotericin B 50 mg | Lyophilized |
| 19 | Teicoplanin for inj. 200 mg | Lyophilized |
| 20 | Teicoplanin for inj. 400 mg | Lyophilized |
| 21 | Dobutamine HCL for inj. 250 mg | Lyophilized |
| 22 | Vecuronium Bromide for ijn. 4 mg | Lyophilized |
| 23 | Vecuronium Bromide for ijn. 10 mg | Lyophilized |
| 24 | Acyclovir Sodium for inj. 250 mg | Lyophilized |
| 25 | Acyclovir Sodium for inj. 500 mg | Lyophilized |
| 26 | Terlipressin Inj. 10 mg | Liquid |
| 27 | Iron Sucrose 100 mg | Liquid |
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||
|
|||
|
|
Note : packing in FFS
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
**Note : Patented products protected by valid patents are not offered for sale in countries where the sale of such products constitutes patent infringement and the liability for patent infringement is exclusively at buyer's risk.
-->






